Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

cbdMD (YCBD) EBIT Margin (2016 - 2025)

Historic EBIT Margin for cbdMD (YCBD) over the last 10 years, with Q3 2025 value amounting to 14.53%.

  • cbdMD's EBIT Margin fell 75800.0% to 14.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.27%, marking a year-over-year increase of 53700.0%. This contributed to the annual value of 11.27% for FY2025, which is 53700.0% up from last year.
  • Per cbdMD's latest filing, its EBIT Margin stood at 14.53% for Q3 2025, which was down 75800.0% from 19.64% recorded in Q2 2025.
  • In the past 5 years, cbdMD's EBIT Margin registered a high of 1.69% during Q4 2024, and its lowest value of 373.55% during Q2 2022.
  • Its 5-year average for EBIT Margin is 79.4%, with a median of 32.2% in 2024.
  • In the last 5 years, cbdMD's EBIT Margin crashed by -3147500bps in 2022 and then surged by 3453300bps in 2023.
  • Quarter analysis of 5 years shows cbdMD's EBIT Margin stood at 255.1% in 2021, then skyrocketed by 75bps to 64.84% in 2022, then surged by 69bps to 19.83% in 2023, then soared by 91bps to 1.69% in 2024, then crashed by -761bps to 14.53% in 2025.
  • Its EBIT Margin stands at 14.53% for Q3 2025, versus 19.64% for Q2 2025 and 10.23% for Q1 2025.